Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Recombinant human residue 41 glutamic acid to glutamine variant of Interferon-alfa-2b

EU orphan designation number: EU/3/08/606
Active ingredient: Recombinant human residue 41 glutamic acid to glutamine variant of Interferon-alfa-2b
Indication: Treatment of Behçet's disease
Sponsor: Creabilis Therapeutics S.p.A.
Bioindustry Park del Canavese, Via Ribes 5, 10010 Colleretto Giacosa (TO), Italia

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/01/2009 Centralised Orphan - Designation EMEA/OD/064/08 (2009)388 of 19/01/2009
11/03/2011 Centralised Orphan - Removal of orphan designation from Community Register